Myeloid‐Derived Growth Factor Improves Endothelial Progenitor Cell Function and Angiogenesis in Mice With Diabetic Hindlimb Ischemia by Activating Akt/HIF‐1α Signalling Pathway
Journal of Cellular and Molecular Medicine · 2026-07 · 30 (13)
DOI: 10.1111/jcmm.71287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 14.07.2026. Verfasst von Wen Mei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, School of Medicine, the Sixth Affiliated Hospital of South China University of Technology (Nanhai District People's Hosp…. Hauptthemen laut MEDLINE: Endothelial Progenitor Cells, Ischemia, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hubei Province of China, the Medical Science and Technology Research Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Myeloid‐derived growth factor (MYDGF) offers new insights into inflammation and endothelial function, yet its role in endothelial progenitor cells (EPCs) and diabetes‐related hindlimb ischemia (DLI) remains unclear. In this study, we found that MYDGF depletion impaired the angiogenic function of EPCs, leading to reduced vascularisation and decreased blood flow in diabetic mice with hindlimb ischemia. Conversely, treatment with adeno‐associated virus–mediated MYDGF restored vascularisation and improved blood perfusion. In vitro, treatment with recombinant MYDGF attenuated EPC dysfunction, apoptosis and inflammatory responses. Mechanistic studies revealed that these protective effects were mediated via the AKT/HIF‐1α pathway, and silencing HIF‐1α abrogated the benefits of MYDGF both in vivo and in vitro. Together, these findings identified MYDGF as a potential therapeutic target for DLI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, School of Medicine, the Sixth Affiliated Hospital of South China University of Technology (Nanhai District People's Hospital of Foshan), Foshan, China.
- Department of Endocrinology, General Hospital of Central Theater Command, Wuhan, China.
- Department of Stomatology, Fuxing Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Yi Shu, Haizhao Luo, Jingwen Ye, Biao Zhu, Jiajia Zhang
Förderung
- Natural Science Foundation of Hubei Province of China
- the Medical Science and Technology Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Mei, W., Meng, B., Zhang, B., Shu, Y., Luo, H., Ye, J., Hou, Y., Zhu, B., & Zhang, J. (2026). Myeloid‐Derived Growth Factor Improves Endothelial Progenitor Cell Function and Angiogenesis in Mice With Diabetic Hindlimb Ischemia by Activating Akt/HIF‐1α Signalling Pathway. Journal of Cellular and Molecular Medicine, 30(13). https://doi.org/10.1111/jcmm.71287
Vancouver
Mei W, Meng B, Zhang B, Shu Y, Luo H, Ye J, et al. Myeloid‐Derived Growth Factor Improves Endothelial Progenitor Cell Function and Angiogenesis in Mice With Diabetic Hindlimb Ischemia by Activating Akt/HIF‐1α Signalling Pathway. Journal of Cellular and Molecular Medicine. 2026;30(13). doi:10.1111/jcmm.71287
BibTeX
@article{Mei2026,
author = {Mei, Wen and Meng, Biying and Zhang, Bilin and Shu, Yi and Luo, Haizhao and Ye, Jingwen and Hou, Yijiang and Zhu, Biao and Zhang, Jiajia},
title = {Myeloid‐Derived Growth Factor Improves Endothelial Progenitor Cell Function and Angiogenesis in Mice With Diabetic Hindlimb Ischemia by Activating Akt/HIF‐1α Signalling Pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {13},
doi = {10.1111/jcmm.71287}
}
EUVIMED